Dr. Roberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-5856
Summary
- Dr. Colin Roberts is a child neurologist based in Portland, Oregon. He received his MD from Jefferson Medical College. He completed pediatric residency at Thomas Jefferson University Hospital and fellowships in Child Neurology and in Epilepsy at the University of Pennsylvania and Children's Hospital of Philadelphia. He founded the Doernbecher Childhood Epilepsy Program at OHSU in 2001, where he is Professor of Pediatrics and Neurology.
Dr. Roberts' clinical experience lies primarily in caring for children with complex epilepsy syndromes. His research has been published in various noteworthy journals, and his work in treatment-resistant epilepsy garnered 51 citations. He has been a principal investigator in many clinical trials focusing on treatments for conditions such as Dravet Syndrome and Lennox-Gastaut Syndrome. He has been recognized as one of Portland's Top Doctors over 15 times by Portland Monthly Magazine.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Epilepsy, 2000 - 2001
- Children's Hospital of PhiladelphiaFellowship, Child Neurology, 1997 - 2000
- Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, WilmingtonResidency, Pediatrics, 1995 - 1997
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1995
Certifications & Licensure
- OR State Medical License 2001 - 2025
- PA State Medical License 1996 - 2002
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- Portland Monthly Magazine Castle Connolly, 2011
Clinical Trials
- A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Start of enrollment: 2013 Apr 29
- A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome Start of enrollment: 2021 Oct 28
Roles: Principal Investigator
- A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome Start of enrollment: 2022 Mar 04
Roles: Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsCannabis Use in Children With Pantothenate Kinase–Associated Neurodegeneration:Jenny L. Wilson, Allison Gregory, Katrina Wakeman, Alison Freed, Puneet Rai
Journal of Child Neurology. 2020-03-01 - Recurrent Episodes of Hypotonia, Encephalopathy, and Quadriparesis in a 3-Year-Old Female.Rachna R. Mamidi, Jared P. Austin, Colin M. Roberts
Clinical Pediatrics. 2020-02-01 - 58 citationsPharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant EpilepsyJames W. Wheless, Dennis J. Dlugos, Ian Miller, D. Alexander Oh, Neha Parikh
CNS Drugs. 2019-06-01
Press Mentions
- Stoke Therapeutics : Presents Data from a Combined Interim Analysis of the Phase 1/2a - Form 8-KDecember 2nd, 2022
- Artificial Intelligence Health and Care Award Competition 1 Phase 1 Stage 2 Funding Panel Meeting MinutesNovember 6th, 2020
- MediCity Helps Raise £26M for 70 New CompaniesNovember 3rd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: